A Welsh NHS Confederation Spokesperson said: “We welcome this report and the recommendations made by the External Affairs and Additional Legislation Committee.
“Since our Director Vanessa Young gave evidence to the Committee, the UK Government and the EU have agreed the terms for withdrawal. The agreement commits to no tariffs on goods and those which were licensed before the transition period will continue to be circulated in the EU, providing reassurances around the supply of medicines after March next year.
“However, should the UK Parliament reject the deal, we once again have uncertainty and the NHS in Wales is therefore continuing to plan for all scenarios.”
“Not only is this the responsible thing to do, but it will also serve to ensure any impact on our health service is significantly reduced. Ultimately our ambition, whatever the deal, is that people in Wales see no difference to the level of healthcare they receive.”
“We will also continue to push for a final agreement that makes sure that patients are guaranteed access to medicines, to research trials, to warning systems on unsafe medicines and outbreaks of infectious disease, and to treatment when working, visiting or living abroad in the EU.”